ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.
The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.
This special issue represents a solid introduction and broad overview of immune-oncology research for physicians and researchers who may be less familiar with this novel field. The articles explore the studies and technologies underpinning the current immune-oncology landscape with a focus on the novel use of immune checkpoint inhibitors in the neoadjuvant setting, using triple negative breast cancer as a paradigm.
Readers will also learn about the techniques and potential benefits of tumour microenvironment manipulation for therapeutic benefit, and more specifically ongoing strategies to potentially overcome cancer resistance to immune checkpoint blockade.Read the full editorial
Watch Dr Nicola Fusco and Elham Sajjadi discuss the topics included in this special issue.